| TARS Tarsus Pharmaceuticals Inc. | 6.98% | 2,454,797 | $126.1M | Add +8.9% |
| LKFT Lakefront Biotherapeutic-ADR filed as GALAPAGOS NV | 5.51% | 3,961,797 | $99.5M | Add +83.3% |
| AUPH Aurinia Pharmaceuticals Inc. | 4.46% | 10,029,500 | $80.6M | Add +19.0% |
| DVAX Dynavax Technologies Corp. | 4.13% | 5,750,000 | $74.6M | Add +210.8% |
| EOLS Evolus Inc. | 3.33% | 4,997,399 | $60.1M | No change |
| KALV Kalvista Pharmaceuticals Inc. | 3.15% | 4,941,798 | $57.0M | Add +1.0% |
| IMCR Immunocore Holdings PLC-ADR | 3.14% | 1,915,708 | $56.8M | Add +23.1% |
| MIRM Mirum Pharmaceuticals Inc. | 3.08% | 1,237,107 | $55.7M | No change |
| PTCT PTC Therapeutics Inc. | 2.82% | 1,000,000 | $51.0M | Add +42.9% |
| KNSA Kiniksa Pharmaceuticals Inte | 2.60% | 2,118,579 | $47.1M | Add +237.0% |
| VRDN Viridian Therapeutics Inc. | 2.08% | 2,792,925 | $37.6M | Add +12.0% |
| SYRE Spyre Therapeutics Inc. | 1.83% | 2,050,000 | $33.1M | New |
| ITCI Intra-Cellular Therapies Inc. | 1.61% | 220,000 | $29.0M | Reduce -26.7% |
| ANAB Anaptysbio Inc. | 1.59% | 1,545,153 | $28.7M | Add +16.1% |
| REPL Replimune Group Inc. | 1.56% | 2,900,000 | $28.3M | Add +7.4% |
| LEGN Legend Biotech Corp.-ADR | 1.56% | 830,000 | $28.2M | Add +84.4% |
| ACAD Acadia Pharmaceuticals Inc. | 1.38% | 1,500,000 | $24.9M | No change |
| BNTX Biontech SE-ADR | 1.36% | 270,000 | $24.6M | No change |
| SLRN Acelyrin Inc. | 1.34% | 9,818,115 | $24.3M | New |
| JAZZ Jazz Pharmaceuticals PLC | 1.30% | 190,000 | $23.6M | Add +35.7% |
| ANIP Ani Pharmaceuticals Inc. | 1.18% | 317,500 | $21.3M | No change |
| RLAY Relay Therapeutics Inc. | 1.17% | 8,068,058 | $21.1M | No change |
| CMPX Compass Therapeutics Inc. | 1.16% | 11,052,632 | $21.0M | Add +87.3% |
| ADMA Adma Biologics Inc. | 1.15% | 1,050,000 | $20.8M | Add +90.9% |
| LENZ Lenz Therapeutics Inc. | 1.09% | 766,940 | $19.7M | No change |
| AZN Astrazeneca PLC-Spons ADR | 1.02% | 250,000 | $18.4M | Add +66.7% |
| LQDA Liquidia Corp. | 0.98% | 1,200,000 | $17.7M | Add +9.1% |
| NBIX Neurocrine Biosciences Inc. | 0.92% | 150,000 | $16.6M | No change |
| AVDL Avadel Pharmaceuticals Ltd. | 0.91% | 2,097,500 | $16.4M | Add +40.1% |
| ITOS Iteos Therapeutics Inc. | 0.89% | 2,689,200 | $16.1M | Add +1112.9% |
| META Meta Platforms Inc. Class A | 0.88% | 27,575 | $15.9M | Add +3.7% |
| GSK GSK PLC-Spon ADR | 0.86% | 400,000 | $15.5M | No change |
| NVDA Nvidia Corp. | 0.85% | 142,569 | $15.5M | No change |
| SNY Sanofi-ADR | 0.83% | 270,000 | $15.0M | No change |
| AVIR Atea Pharmaceuticals Inc. | 0.79% | 4,800,000 | $14.4M | Add +0.2% |
| ALT Altimmune Inc. | 0.76% | 2,750,000 | $13.8M | No change |
| ZYME Zymeworks Inc. | 0.72% | 1,100,000 | $13.1M | No change |
| NKTX Nkarta Inc. | 0.72% | 7,055,576 | $13.0M | Add +207.6% |
| CRGX Cargo Therapeutics Inc. | 0.69% | 3,059,630 | $12.5M | Add +378.1% |
| HELP Cybin Inc. | 0.64% | 1,830,097 | $11.6M | Add +37.6% |
| PCVX Vaxcyte Inc. | 0.63% | 300,000 | $11.3M | No change |
| KROS Keros Therapeutics Inc. | 0.62% | 1,100,000 | $11.2M | New |
| TDOC Teladoc Health Inc. | 0.62% | 1,400,000 | $11.1M | No change |
| DERM Journey Medical Corp. | 0.61% | 1,854,596 | $10.9M | Add +7.5% |
| VNDA Vanda Pharmaceuticals Inc. | 0.60% | 2,353,307 | $10.8M | No change |
| ONC Beone Medicines Ltd.-ADR filed as BEIGENE LTD | 0.56% | 37,000 | $10.1M | No change |
| ARVN Arvinas Inc. | 0.54% | 1,393,800 | $9.8M | New |
| HRMY Harmony Biosciences Holdings | 0.52% | 281,200 | $9.3M | No change |
| BABA Alibaba Group Holding-SP ADR | 0.51% | 70,000 | $9.3M | New |
| CRSP Crispr Therapeutics AG | 0.50% | 266,500 | $9.1M | No change |
| MRNA Moderna Inc. | 0.48% | 305,300 | $8.7M | Add +1.8% |
| CGEM Cullinan Therapeutics Inc. | 0.47% | 1,121,138 | $8.5M | Add +21.7% |
| ELAN Elanco Animal Health Inc. | 0.46% | 800,100 | $8.4M | Add +0.0% |
| PLRX Pliant Therapeutics Inc. | 0.45% | 6,000,000 | $8.1M | New |
| BLCO Bausch + Lomb Corp. | 0.44% | 550,000 | $8.0M | Add +22.2% |
| INSM Insmed Inc. | 0.42% | 100,000 | $7.6M | No change |
| PHAT Phathom Pharmaceuticals Inc. | 0.42% | 1,200,000 | $7.5M | Add +140.0% |
| APGE Apogee Therapeutics Inc. | 0.41% | 200,000 | $7.5M | Add +100.0% |
| HLVX Hillevax Inc. | 0.39% | 4,920,000 | $7.1M | No change |
| IBRX Immunitybio Inc. | 0.39% | 2,333,333 | $7.0M | Reduce -17.1% |
| NUVB Nuvation Bio Inc. | 0.38% | 3,900,000 | $6.9M | No change |
| EPIX Essa Pharma Inc. | 0.38% | 4,300,000 | $6.8M | No change |
| EWTX Edgewise Therapeutics Inc. | 0.37% | 300,000 | $6.6M | No change |
| VKTX Viking Therapeutics Inc. | 0.36% | 270,000 | $6.5M | Reduce -15.6% |
| DSGN Design Therapeutics Inc. | 0.36% | 1,680,975 | $6.5M | Add +13.5% |
| REGN Regeneron Pharmaceuticals | 0.35% | 10,000 | $6.3M | Add +400.0% |
| ACET Adicet Bio Inc. | 0.34% | 8,223,612 | $6.2M | Add +0.9% |
| BIOA Bioage Labs Inc. | 0.33% | 1,600,000 | $6.0M | Add +21.4% |
| BCRX Biocryst Pharmaceuticals Inc. | 0.33% | 800,000 | $6.0M | No change |
| IOVA Iovance Biotherapeutics Inc. | 0.33% | 1,800,000 | $6.0M | Add +260.0% |
| ABCL Abcellera Biologics Inc. | 0.32% | 2,600,000 | $5.8M | Add +0.7% |
| RCKT Rocket Pharmaceuticals Inc. | 0.31% | 850,000 | $5.7M | Add +13.3% |
| HRTX Heron Therapeutics Inc. | 0.27% | 2,235,459 | $4.9M | Add +4.5% |
| LNTH Lantheus Holdings Inc. | 0.27% | 50,000 | $4.9M | No change |
| DNTH Dianthus Therapeutics Inc. | 0.27% | 264,692 | $4.8M | No change |
| BIIB Biogen Inc. | 0.27% | 35,000 | $4.8M | No change |
| IONS Ionis Pharmaceuticals Inc. | 0.25% | 150,000 | $4.5M | No change |
| CTMX Cytomx Therapeutics Inc. | 0.24% | 6,717,825 | $4.3M | Reduce -8.1% |
| MRUS Merus NV | 0.23% | 100,000 | $4.2M | No change |
| CHRS Coherus Oncology Inc. | 0.23% | 5,097,362 | $4.1M | Add +39.6% |
| JANX Janux Therapeutics Inc. | 0.22% | 150,000 | $4.0M | Add +200.0% |
| CYTK Cytokinetics Inc. | 0.22% | 100,000 | $4.0M | No change |
| CMPS Compass Pathways PLC | 0.22% | 1,400,000 | $4.0M | Add +40.0% |
| TGTX TG Therapeutics Inc. | 0.22% | 100,000 | $3.9M | No change |
| GMAB Genmab A/S -SP ADR | 0.22% | 200,000 | $3.9M | Add +100.0% |
| NVAX Novavax Inc. | 0.21% | 600,000 | $3.8M | No change |
| ARE Alexandria Real Estate Equit | 0.20% | 40,000 | $3.7M | No change |
| VERA Vera Therapeutics Inc. | 0.20% | 150,000 | $3.6M | New |
| SLNO Soleno Therapeutics Inc. | 0.20% | 50,000 | $3.6M | No change |
| VTYX Ventyx Biosciences Inc. | 0.20% | 3,100,000 | $3.6M | No change |
| NUVL Nuvalent Inc. Class A | 0.20% | 50,000 | $3.5M | No change |
| RVMD Revolution Medicines Inc. | 0.20% | 100,000 | $3.5M | No change |
| KZR Kezar Life Sciences Inc. | 0.19% | 720,000 | $3.5M | No change |
| BHVN Biohaven Ltd. | 0.19% | 140,000 | $3.4M | No change |
| STOK Stoke Therapeutics Inc. | 0.18% | 500,000 | $3.3M | Add +66.7% |
| SWTX Springworks Therapeutics Inc. | 0.18% | 74,265 | $3.3M | No change |
| VIR Vir Biotechnology Inc. | 0.18% | 500,000 | $3.2M | New |
| THRD Third Harmonic Bio Inc. | 0.18% | 929,727 | $3.2M | Add +519.8% |
| DTIL Precision Biosciences Inc. | 0.18% | 673,332 | $3.2M | No change |
| BDTX Black Diamond Therapeutics I | 0.18% | 2,070,209 | $3.2M | No change |